US 11939581
Methods and compositions for targeting PD-L1
granted A61KA61K31/7105A61K45/06
Quick answer
US patent 11939581 (Methods and compositions for targeting PD-L1) held by Aligos Therapeutics, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7105, A61K45/06, A61P, A61P31/20